admin
The medical case for giving puberty blockers and cross‑sex hormones to children just took a big hit. A new peer‑reviewed critique says three decades of research behind the so‑called Dutch Protocol “has not produced reliable evidence.” That is not academic hair‑splitting. It is a challenge to the scientific footing of a practice that has real and lasting effects on kids’ bodies and lives.
New review rips apart the Dutch Protocol evidence
A peer‑reviewed paper by Kathleen McDeavitt and J. Cohn examines the Amsterdam clinic studies that built the Dutch Protocol. The authors conclude the evidence is weak, full of selection bias, and missing the kinds of controls that would let doctors say the treatments caused the reported benefits. In plain language: the studies tracked small, selected groups, dropped patients along the way, changed measurement methods, and never ran randomized trials. That combination makes confident claims about long‑term mental‑health benefits or safety impossible.
What the critics found — and why it matters
The review highlights three big problems: cherry‑picked samples, shifting outcome measures, and poor tracking of harms. Kids who left treatment, developed health problems, or worse, were not always counted in later reports. Long‑term risks like heart disease and fertility effects were rarely followed. Where mental‑health scores improved, the changes were small and of unclear meaning. For parents and policymakers, that means the “science” being used to justify medical transition for minors may be thinner than advertised.
Political fallout and the call for answers
The paper has already reached the halls of power in the Netherlands. A member of parliament has filed formal questions to the health minister, asking whether the government will take the critique into account in national reviews and quality standards. That is the right kind of reaction. If the foundational studies are flawed, national guidance and clinical confidence should be re‑examined. This is not about shaming clinicians — it is about demanding honest science when kids’ futures are at stake.
What needs to happen next
Doctors and regulators must stop treating strong claims as settled facts. We need transparent data, better follow‑up on long‑term harms, appropriate comparison groups, and yes, higher methodological standards before irreversible treatments are normalized for children. Policymakers should press for accountability, not platitudes. Parents deserve clear answers, not scientific spin. If the Dutch Protocol’s research cannot stand up to scrutiny, then the rush to medicalize childhood confusion should stop until it can.
